MARKET

BIO

BIO

Bio Rad Labs Inc
NYSE
293.70
+13.57
+4.84%
Opening 10:25 04/23 EDT
OPEN
--
PREV CLOSE
280.13
HIGH
294.33
LOW
--
VOLUME
39.79K
TURNOVER
--
52 WEEK HIGH
473.50
52 WEEK LOW
261.59
MARKET CAP
8.38B
P/E (TTM)
-13.4605
1D
5D
1M
3M
1Y
5Y
Danaher gains as Q1 results exceed expectations
Danaher (DHR) shares added ~9% premarket Tuesday after the company topped Street forecasts with its Q1 2024 financials. The life sciences toolmaker reported $5.8B in revenue for the quarter with a 3% YoY decline in sales.
Seeking Alpha · 5h ago
BIO-RAD LABORATORIES INC REPORTS 8.99% PASSIVE STAKE IN ONCOCYTE CORP AS OF APRIL 15 - SEC FILING
Reuters · 22h ago
Goldman’s debt issuers stocks basket
Seeking Alpha · 23h ago
Weekly Report: what happened at BIO last week (0415-0419)?
Weekly Report · 1d ago
New Strong Sell Stocks for April 19th
NASDAQ · 4d ago
Thursday Sector Laggards: Technology & Communications, Healthcare
NASDAQ · 4d ago
96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?
April has marked the bleakest month for the U.S. Stock market since September 2023. The S&P 500 index has fallen by 3.7% this month, with 480 out of 500 companies in the index trading at lower market values compared to analysts’ price targets. The top 5 contrarian stocks within the S&p 500 index exhibit the most pronounced gap between current prices and median targets.
Benzinga · 4d ago
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
NASDAQ · 5d ago
More
About BIO
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Webull offers Bio Rad Laboratories Inc stock information, including NYSE: BIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIO stock methods without spending real money on the virtual paper trading platform.